Table of Content

1 Cobamamide for Injection Market Overview
1.1 Product Overview and Scope of Cobamamide for Injection
1.2 Cobamamide for Injection Segment by Type
1.2.1 Global Cobamamide for Injection Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 0.5mg
1.2.3 1.0mg
1.2.4 1.5mg
1.3 Cobamamide for Injection Segment by Application
1.3.1 Cobamamide for Injection Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Global Cobamamide for Injection Market Size Estimates and Forecasts
1.4.1 Global Cobamamide for Injection Revenue 2016-2027
1.4.2 Global Cobamamide for Injection Sales 2016-2027
1.4.3 Cobamamide for Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Cobamamide for Injection Market Competition by Manufacturers
2.1 Global Cobamamide for Injection Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cobamamide for Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cobamamide for Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cobamamide for Injection Manufacturing Sites, Area Served, Product Type
2.5 Cobamamide for Injection Market Competitive Situation and Trends
2.5.1 Cobamamide for Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cobamamide for Injection Players Market Share by Revenue
2.5.3 Global Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cobamamide for Injection Retrospective Market Scenario by Region
3.1 Global Cobamamide for Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Cobamamide for Injection Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Cobamamide for Injection Market Facts & Figures by Country
3.3.1 North America Cobamamide for Injection Sales by Country
3.3.2 North America Cobamamide for Injection Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cobamamide for Injection Market Facts & Figures by Country
3.4.1 Europe Cobamamide for Injection Sales by Country
3.4.2 Europe Cobamamide for Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cobamamide for Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Cobamamide for Injection Sales by Region
3.5.2 Asia Pacific Cobamamide for Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cobamamide for Injection Market Facts & Figures by Country
3.6.1 Latin America Cobamamide for Injection Sales by Country
3.6.2 Latin America Cobamamide for Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cobamamide for Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Cobamamide for Injection Sales by Country
3.7.2 Middle East and Africa Cobamamide for Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cobamamide for Injection Historic Market Analysis by Type
4.1 Global Cobamamide for Injection Sales Market Share by Type (2016-2021)
4.2 Global Cobamamide for Injection Revenue Market Share by Type (2016-2021)
4.3 Global Cobamamide for Injection Price by Type (2016-2021)

5 Global Cobamamide for Injection Historic Market Analysis by Application
5.1 Global Cobamamide for Injection Sales Market Share by Application (2016-2021)
5.2 Global Cobamamide for Injection Revenue Market Share by Application (2016-2021)
5.3 Global Cobamamide for Injection Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Haerbin Medisan
6.1.1 Haerbin Medisan Corporation Information
6.1.2 Haerbin Medisan Description and Business Overview
6.1.3 Haerbin Medisan Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Haerbin Medisan Product Portfolio
6.1.5 Haerbin Medisan Recent Developments/Updates
6.2 North China Pharmaceutical Group
6.2.1 North China Pharmaceutical Group Corporation Information
6.2.2 North China Pharmaceutical Group Description and Business Overview
6.2.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
6.2.4 North China Pharmaceutical Group Product Portfolio
6.2.5 North China Pharmaceutical Group Recent Developments/Updates
6.3 Chongqing Yaoyou Pharmaceutical
6.3.1 Chongqing Yaoyou Pharmaceutical Corporation Information
6.3.2 Chongqing Yaoyou Pharmaceutical Description and Business Overview
6.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Chongqing Yaoyou Pharmaceutical Product Portfolio
6.3.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
6.4 Hainan Star Pharmaceutical
6.4.1 Hainan Star Pharmaceutical Corporation Information
6.4.2 Hainan Star Pharmaceutical Description and Business Overview
6.4.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hainan Star Pharmaceutical Product Portfolio
6.4.5 Hainan Star Pharmaceutical Recent Developments/Updates
6.5 Hebei Zhitong Biopharmaceutical
6.5.1 Hebei Zhitong Biopharmaceutical Corporation Information
6.5.2 Hebei Zhitong Biopharmaceutical Description and Business Overview
6.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hebei Zhitong Biopharmaceutical Product Portfolio
6.5.5 Hebei Zhitong Biopharmaceutical Recent Developments/Updates
6.6 Jiangsu Jiuxu Pharmaceutical
6.6.1 Jiangsu Jiuxu Pharmaceutical Corporation Information
6.6.2 Jiangsu Jiuxu Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Jiangsu Jiuxu Pharmaceutical Product Portfolio
6.6.5 Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
6.7 Jiuquan Dadeli pharmaceutical
6.6.1 Jiuquan Dadeli pharmaceutical Corporation Information
6.6.2 Jiuquan Dadeli pharmaceutical Description and Business Overview
6.6.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jiuquan Dadeli pharmaceutical Product Portfolio
6.7.5 Jiuquan Dadeli pharmaceutical Recent Developments/Updates

7 Cobamamide for Injection Manufacturing Cost Analysis
7.1 Cobamamide for Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cobamamide for Injection
7.4 Cobamamide for Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cobamamide for Injection Distributors List
8.3 Cobamamide for Injection Customers

9 Cobamamide for Injection Market Dynamics
9.1 Cobamamide for Injection Industry Trends
9.2 Cobamamide for Injection Growth Drivers
9.3 Cobamamide for Injection Market Challenges
9.4 Cobamamide for Injection Market Restraints

10 Global Market Forecast
10.1 Cobamamide for Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cobamamide for Injection by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cobamamide for Injection by Type (2022-2027)
10.2 Cobamamide for Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cobamamide for Injection by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cobamamide for Injection by Application (2022-2027)
10.3 Cobamamide for Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cobamamide for Injection by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cobamamide for Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Cobamamide for Injection Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Cobamamide for Injection Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Cobamamide for Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Cobamamide for Injection Covered in This Study
Table 5. Global Cobamamide for Injection Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Cobamamide for Injection Sales Share by Manufacturers (2016-2021)
Table 7. Global Cobamamide for Injection Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Cobamamide for Injection Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Cobamamide for Injection Average Price (US$/g) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Cobamamide for Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Cobamamide for Injection Product Type
Table 12. Global Cobamamide for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cobamamide for Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cobamamide for Injection as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cobamamide for Injection Sales by Region (2016-2021) & (Kg)
Table 16. Global Cobamamide for Injection Sales Market Share by Region (2016-2021)
Table 17. Global Cobamamide for Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Cobamamide for Injection Sales by Country (2016-2021) & (Kg)
Table 19. North America Cobamamide for Injection Sales Market Share by Country (2016-2021)
Table 20. North America Cobamamide for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Cobamamide for Injection Revenue Market Share by Country (2016-2021)
Table 22. Europe Cobamamide for Injection Sales by Country (2016-2021) & (Kg)
Table 23. Europe Cobamamide for Injection Sales Market Share by Country (2016-2021)
Table 24. Europe Cobamamide for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Cobamamide for Injection Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Cobamamide for Injection Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Cobamamide for Injection Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Cobamamide for Injection Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Cobamamide for Injection Revenue Market Share by Region (2016-2021)
Table 30. Latin America Cobamamide for Injection Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Cobamamide for Injection Sales Market Share by Country (2016-2021)
Table 32. Latin America Cobamamide for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Cobamamide for Injection Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Cobamamide for Injection Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Cobamamide for Injection Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Cobamamide for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Cobamamide for Injection Revenue Market Share by Country (2016-2021)
Table 38. Global Cobamamide for Injection Sales (Kg) by Type (2016-2021)
Table 39. Global Cobamamide for Injection Sales Market Share by Type (2016-2021)
Table 40. Global Cobamamide for Injection Revenue (Million US$) by Type (2016-2021)
Table 41. Global Cobamamide for Injection Revenue Share by Type (2016-2021)
Table 42. Global Cobamamide for Injection Price (US$/g) by Type (2016-2021)
Table 43. Global Cobamamide for Injection Sales (Kg) by Application (2016-2021)
Table 44. Global Cobamamide for Injection Sales Market Share by Application (2016-2021)
Table 45. Global Cobamamide for Injection Revenue (Million US$) by Application (2016-2021)
Table 46. Global Cobamamide for Injection Revenue Share by Application (2016-2021)
Table 47. Global Cobamamide for Injection Price (US$/g) by Application (2016-2021)
Table 48. Haerbin Medisan Corporation Information
Table 49. Haerbin Medisan Description and Business Overview
Table 50. Haerbin Medisan Cobamamide for Injection Sales (Kg), Revenue (Million US$), Price (US$/g) and Gross Margin (2016-2021)
Table 51. Haerbin Medisan Cobamamide for Injection Product
Table 52. Haerbin Medisan Recent Developments/Updates
Table 53. North China Pharmaceutical Group Corporation Information
Table 54. North China Pharmaceutical Group Description and Business Overview
Table 55. North China Pharmaceutical Group Cobamamide for Injection Sales (Kg), Revenue (Million US$), Price (US$/g) and Gross Margin (2016-2021)
Table 56. North China Pharmaceutical Group Cobamamide for Injection Product
Table 57. North China Pharmaceutical Group Recent Developments/Updates
Table 58. Chongqing Yaoyou Pharmaceutical Corporation Information
Table 59. Chongqing Yaoyou Pharmaceutical Description and Business Overview
Table 60. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million US$), Price (US$/g) and Gross Margin (2016-2021)
Table 61. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product
Table 62. Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
Table 63. Hainan Star Pharmaceutical Corporation Information
Table 64. Hainan Star Pharmaceutical Description and Business Overview
Table 65. Hainan Star Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million US$), Price (US$/g) and Gross Margin (2016-2021)
Table 66. Hainan Star Pharmaceutical Cobamamide for Injection Product
Table 67. Hainan Star Pharmaceutical Recent Developments/Updates
Table 68. Hebei Zhitong Biopharmaceutical Corporation Information
Table 69. Hebei Zhitong Biopharmaceutical Description and Business Overview
Table 70. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million US$), Price (US$/g) and Gross Margin (2016-2021)
Table 71. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product
Table 72. Hebei Zhitong Biopharmaceutical Recent Developments/Updates
Table 73. Jiangsu Jiuxu Pharmaceutical Corporation Information
Table 74. Jiangsu Jiuxu Pharmaceutical Description and Business Overview
Table 75. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million US$), Price (US$/g) and Gross Margin (2016-2021)
Table 76. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product
Table 77. Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
Table 78. Jiuquan Dadeli pharmaceutical Corporation Information
Table 79. Jiuquan Dadeli pharmaceutical Description and Business Overview
Table 80. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million US$), Price (US$/g) and Gross Margin (2016-2021)
Table 81. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product
Table 82. Jiuquan Dadeli pharmaceutical Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Cobamamide for Injection Distributors List
Table 86. Cobamamide for Injection Customers List
Table 87. Cobamamide for Injection Market Trends
Table 88. Cobamamide for Injection Growth Drivers
Table 89. Cobamamide for Injection Market Restraints
Table 90. Global Cobamamide for Injection Sales Forecast by Type (2022-2027) & (Kg)
Table 91. Global Cobamamide for Injection Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Cobamamide for Injection Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Cobamamide for Injection Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Cobamamide for Injection Sales Forecast by Application (2022-2027) & (Kg)
Table 95. Global Cobamamide for Injection Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Cobamamide for Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Cobamamide for Injection Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Cobamamide for Injection Sales Forecast by Region (2022-2027) & (Kg)
Table 99. Global Cobamamide for Injection Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Cobamamide for Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Cobamamide for Injection Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cobamamide for Injection
Figure 2. Global Cobamamide for Injection Market Share by Type in 2020 & 2027
Figure 3. 0.5mg Product Picture
Figure 4. 1.0mg Product Picture
Figure 5. 1.5mg Product Picture
Figure 6. Global Cobamamide for Injection Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Drug Store
Figure 9. Other
Figure 10. Global Cobamamide for Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cobamamide for Injection Market Size 2016-2027 (US$ Million)
Figure 12. Global Cobamamide for Injection Sales 2016-2027 (Kg)
Figure 13. Global Cobamamide for Injection Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Cobamamide for Injection Sales Share by Manufacturers in 2020
Figure 15. Global Cobamamide for Injection Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Cobamamide for Injection Players: Market Share by Revenue in 2020
Figure 17. Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Cobamamide for Injection Sales Market Share by Region (2016-2021)
Figure 19. Global Cobamamide for Injection Sales Market Share by Region in 2020
Figure 20. Global Cobamamide for Injection Revenue Market Share by Region (2016-2021)
Figure 21. Global Cobamamide for Injection Revenue Market Share by Region in 2020
Figure 22. U.S. Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Cobamamide for Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Cobamamide for Injection by Type (2016-2021)
Figure 47. Sales Market Share of Cobamamide for Injection by Application (2016-2021)
Figure 48. Sales Market Share of Cobamamide for Injection by Application in 2020
Figure 49. Revenue Share of Cobamamide for Injection by Application (2016-2021)
Figure 50. Revenue Share of Cobamamide for Injection by Application in 2020
Figure 51. Manufacturing Cost Structure of Cobamamide for Injection
Figure 52. Manufacturing Process Analysis of Cobamamide for Injection
Figure 53. Cobamamide for Injection Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed